RhumbLine Advisers’s Biodexa Pharmaceuticals BDRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $59 | Sell |
7
-25
| -78% | -$211 | ﹤0.01% | 4113 |
|
|
2025
Q1 | $414 | Buy |
32
+17
| +113% | +$220 | ﹤0.01% | 4066 |
|
|
2024
Q4 | $628 | Sell |
15
-9
| -38% | -$377 | ﹤0.01% | 4094 |
|
|
2024
Q3 | $1.7K | Buy |
24
+13
| +118% | +$921 | ﹤0.01% | 4067 |
|
|
2024
Q2 | $2.43K | Buy |
11
+9
| +450% | +$1.98K | ﹤0.01% | 4168 |
|
|
2024
Q1 | $806 | Hold |
2
| – | – | ﹤0.01% | 4162 |
|
|
2023
Q4 | $1.33K | Buy |
2
+1
| +100% | +$666 | ﹤0.01% | 4130 |
|
|
2023
Q3 | $1.09K | Buy |
+1
| New | +$1.09K | ﹤0.01% | 4174 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 4362 |
|